Elevidys (Delandistrogene Moxeparvovec) for Duchenne Muscular Dystrophy
Type: gene_therapy
Status: FDA Approved (Accelerated Approval)
Developer: Sarepta Therapeutics
Breakthrough Summary
No summary available.
Mechanism of Action
Details pending.
Year: 2026